LONG COVID19
Clinical trials for LONG COVID19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID19 trials appear
Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a scavenger pill calm the long COVID storm?
Disease control Recruiting nowThis study is testing if a compound called 2-HOBA can help people with Long COVID who also have POTS, a condition causing dizziness and a racing heart when standing. Researchers believe an overactive immune response after the initial infection drives these symptoms. Over 28 days,…
Matched conditions: LONG COVID19
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Weight loss drug could protect brain function in chronic illness
Knowledge-focused Recruiting nowThis study is testing whether a weight loss medication called liraglutide (Saxenda) affects brain health markers in people with multiple sclerosis, long COVID, or leukemia in remission who also have obesity and cognitive problems. Researchers will measure changes in a protein cal…
Matched conditions: LONG COVID19
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC